Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Reply to Askew and Green.

Causer AJ, Shute JK, Cummings MH, Shepherd AI, Bright V, Connett G, Allenby MI, Carroll MP, Daniels T, Saynor ZL.

J Appl Physiol (1985). 2019 Feb 1;126(2):512. doi: 10.1152/japplphysiol.00939.2018. No abstract available.

PMID:
30799675
2.

Reply to Cooper.

Causer AJ, Shute JK, Cummings MH, Shepherd AI, Bright V, Connett G, Allenby MI, Carroll MP, Daniels T, Saynor ZL.

J Appl Physiol (1985). 2019 Jan 1;126(1):265. doi: 10.1152/japplphysiol.00839.2018. No abstract available.

PMID:
30694712
3.

Determining the reasons for poorly controlled asthma in an adolescent.

Connett GJ, Connett LA, Thomas M.

BMJ. 2019 Jan 21;364:l75. doi: 10.1136/bmj.l75. No abstract available.

PMID:
30665959
4.

Dysfunctional Breathing in Children and Adults With Asthma.

Connett GJ, Thomas M.

Front Pediatr. 2018 Dec 20;6:406. doi: 10.3389/fped.2018.00406. eCollection 2018. Review.

5.

Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI).

Johnson CD, Williamson N, Janssen-van Solingen G, Arbuckle R, Johnson C, Simpson S, Staab D, Dominguez-Munoz E, Levy P, Connett G, Lerch MM.

Pancreatology. 2019 Jan;19(1):182-190. doi: 10.1016/j.pan.2018.11.013. Epub 2018 Nov 27.

6.

Cardiopulmonary exercise testing with supramaximal verification produces a safe and valid assessment of V̇o2max in people with cystic fibrosis: a retrospective analysis.

Causer AJ, Shute JK, Cummings MH, Shepherd AI, Bright V, Connett G, Allenby MI, Carroll MP, Daniels T, Saynor ZL.

J Appl Physiol (1985). 2018 Oct 1;125(4):1277-1283. doi: 10.1152/japplphysiol.00454.2018. Epub 2018 Aug 2.

PMID:
30346240
7.

Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review.

Pammi M, Lal CV, Wagner BD, Mourani PM, Lohmann P, Luna RA, Sisson A, Shivanna B, Hollister EB, Abman SH, Versalovic J, Connett GJ, Bhandari V, Ambalavanan N.

J Pediatr. 2019 Jan;204:126-133.e2. doi: 10.1016/j.jpeds.2018.08.042. Epub 2018 Oct 5.

PMID:
30297287
8.

CARDIOPULMONARY EXERCISE TESTING WITH SUPRAMAXIMAL VERIFICATION PRODUCES A SAFE AND VALID ASSESSMENT OF V̇O2max IN PEOPLE WITH CYSTIC FIBROSIS.

Causer AJ, Shute JK, Cummings MH, Shepherd AI, Bright V, Connett G, Allenby MI, Carroll MP, Daniels T, Saynor ZL.

J Appl Physiol (1985). 2018 Aug 2. doi: 10.1152/japplphysiol.00454.2018. [Epub ahead of print]

PMID:
30070605
9.

Ready, Steady, Go - Achieving successful transition in cystic fibrosis.

Connett GJ, Nagra A.

Paediatr Respir Rev. 2018 Jun;27:13-15. doi: 10.1016/j.prrv.2018.05.007. Epub 2018 May 18. Review.

PMID:
29914748
10.

The use of lumacaftor/ivacaftor to treat acute deterioration in paediatric cystic fibrosis.

Hammond JA, Connett GJ.

Paediatr Respir Rev. 2018 Jun;27:16-17. doi: 10.1016/j.prrv.2018.05.008. Epub 2018 May 19.

PMID:
29914743
11.

Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Smith WD, Bardin E, Cameron L, Edmondson CL, Farrant KV, Martin I, Murphy RA, Soren O, Turnbull AR, Wierre-Gore N, Alton EW, Bundy JG, Bush A, Connett GJ, Faust SN, Filloux A, Freemont PS, Jones AL, Takats Z, Webb JS, Williams HD, Davies JC.

FEMS Microbiol Lett. 2017 Aug 1;364(14). doi: 10.1093/femsle/fnx121. Review.

PMID:
28854668
12.

Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Howlin RP, Cathie K, Hall-Stoodley L, Cornelius V, Duignan C, Allan RN, Fernandez BO, Barraud N, Bruce KD, Jefferies J, Kelso M, Kjelleberg S, Rice SA, Rogers GB, Pink S, Smith C, Sukhtankar PS, Salib R, Legg J, Carroll M, Daniels T, Feelisch M, Stoodley P, Clarke SC, Connett G, Faust SN, Webb JS.

Mol Ther. 2017 Sep 6;25(9):2104-2116. doi: 10.1016/j.ymthe.2017.06.021. Epub 2017 Jul 24.

13.

Contributions of Composition and Interactions to Bacterial Respiration Are Reliant on the Phylogenetic Similarity of the Measured Community.

Rivett DW, Lilley AK, Connett GJ, Carroll MP, Legg JP, Bruce KD.

Microb Ecol. 2017 Oct;74(3):757-760. doi: 10.1007/s00248-017-0982-2. Epub 2017 Apr 27.

14.

Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.

Johnson CD, Arbuckle R, Bonner N, Connett G, Dominguez-Munoz E, Levy P, Staab D, Williamson N, Lerch MM.

Patient. 2017 Oct;10(5):615-628. doi: 10.1007/s40271-017-0233-0.

15.

Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms.

Collins SA, Kelso MJ, Rineh A, Yepuri NR, Coles J, Jackson CL, Halladay GD, Walker WT, Webb JS, Hall-Stoodley L, Connett GJ, Feelisch M, Faust SN, Lucas JS, Allan RN.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02086-16. doi: 10.1128/AAC.02086-16. Print 2017 Feb.

16.

Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches.

Lund-Palau H, Turnbull AR, Bush A, Bardin E, Cameron L, Soren O, Wierre-Gore N, Alton EW, Bundy JG, Connett G, Faust SN, Filloux A, Freemont P, Jones A, Khoo V, Morales S, Murphy R, Pabary R, Simbo A, Schelenz S, Takats Z, Webb J, Williams HD, Davies JC.

Expert Rev Respir Med. 2016 Jun;10(6):685-97. doi: 10.1080/17476348.2016.1177460. Epub 2016 May 13. Review.

17.

Cystic Fibrosis Nutrition--Chewing the Fat.

Connett GJ.

Paediatr Respir Rev. 2016 Jan;17:42-4. doi: 10.1016/j.prrv.2015.08.006. Epub 2015 Oct 31.

PMID:
26527359
18.

Nutritional outcomes in cystic fibrosis - are we doing enough?

Connett GJ, Pike KC.

Paediatr Respir Rev. 2015 Oct;16 Suppl 1:31-4. doi: 10.1016/j.prrv.2015.07.015. Epub 2015 Sep 26. Review.

PMID:
26410288
19.

Routine use of daily oral vitamin K to treat infants with cystic fibrosis.

Cottam ST, Connett GJ.

Paediatr Respir Rev. 2015 Oct;16 Suppl 1:22-4. doi: 10.1016/j.prrv.2015.07.012. Epub 2015 Sep 26. Review.

PMID:
26410287
20.

Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.

Connett GJ, Pike KC, Legg JP, Cathie K, Dewar A, Foote K, Harris A, Faust SN.

Ther Adv Respir Dis. 2015 Dec;9(6):272-80. doi: 10.1177/1753465815601571. Epub 2015 Sep 4.

PMID:
26341118

Supplemental Content

Loading ...
Support Center